Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Pre-Infusion Host-Marrow Vulnerability in CD19- and BCMA-Directed CAR T-Cell Therapy: Clonal Hematopoiesis, Hematotoxicity, and Therapy-Related Myeloid Neoplasia

Saved in:
Bibliographic Details
Published in:Cancer Management and Research
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871203157595389952
collection WordPress RSS
FRELIP Feed Integration
container_title Cancer Management and Research
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:104379
institution FRELIP
journal_source_facet Cancer Management and Research
last_indexed 2026-07-20T03:33:11.357Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Pre-Infusion Host-Marrow Vulnerability in CD19- and BCMA-Directed CAR T-Cell Therapy: Clonal Hematopoiesis, Hematotoxicity, and Therapy-Related Myeloid Neoplasia
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Pre-Infusion Host-Marrow Vulnerability in CD19- and BCMA-Directed CAR T-Cell Therapy: Clonal Hematopoiesis, Hematotoxicity, and Therapy-Related Myeloid Neoplasia
title_alt Vulnerabilidad de la médula del huésped previa a la infusión en la terapia con células CAR-T dirigidas a CD19 y BCMA: hematopoyesis clonal, hematotoxicidad y neoplasia mieloide relacionada con la terapia
Vulnérabilité de la moelle hôte avant perfusion dans la thérapie par cellules CAR-T dirigées contre CD19 et BCMA : hématopoïèse clonale, hématotoxicité et néoplasie myéloïde liée au traitement
Vulnerabilidade da Medula Óssea do Hospedeiro Pré-Infusão na Terapia com Células CAR-T Dirigidas a CD19 e BCMA: Hematopoiese Clonal, Hematotoxicidade e Neoplasia Mieloide Relacionada à Terapia
title_auth Pre-Infusion Host-Marrow Vulnerability in CD19- and BCMA-Directed CAR T-Cell Therapy: Clonal Hematopoiesis, Hematotoxicity, and Therapy-Related Myeloid Neoplasia
title_es_txt Vulnerabilidad de la médula del huésped previa a la infusión en la terapia con células CAR-T dirigidas a CD19 y BCMA: hematopoyesis clonal, hematotoxicidad y neoplasia mieloide relacionada con la terapia
title_fr_txt Vulnérabilité de la moelle hôte avant perfusion dans la thérapie par cellules CAR-T dirigées contre CD19 et BCMA : hématopoïèse clonale, hématotoxicité et néoplasie myéloïde liée au traitement
title_full Pre-Infusion Host-Marrow Vulnerability in CD19- and BCMA-Directed CAR T-Cell Therapy: Clonal Hematopoiesis, Hematotoxicity, and Therapy-Related Myeloid Neoplasia
title_fullStr Pre-Infusion Host-Marrow Vulnerability in CD19- and BCMA-Directed CAR T-Cell Therapy: Clonal Hematopoiesis, Hematotoxicity, and Therapy-Related Myeloid Neoplasia
title_full_unstemmed Pre-Infusion Host-Marrow Vulnerability in CD19- and BCMA-Directed CAR T-Cell Therapy: Clonal Hematopoiesis, Hematotoxicity, and Therapy-Related Myeloid Neoplasia
title_pt_txt Vulnerabilidade da Medula Óssea do Hospedeiro Pré-Infusão na Terapia com Células CAR-T Dirigidas a CD19 e BCMA: Hematopoiese Clonal, Hematotoxicidade e Neoplasia Mieloide Relacionada à Terapia
title_short Pre-Infusion Host-Marrow Vulnerability in CD19- and BCMA-Directed CAR T-Cell Therapy: Clonal Hematopoiesis, Hematotoxicity, and Therapy-Related Myeloid Neoplasia
title_sort pre-infusion host-marrow vulnerability in cd19- and bcma-directed car t-cell therapy: clonal hematopoiesis, hematotoxicity, and therapy-related myeloid neoplasia
topic Oncology
General
Oncology
url https://www.dovepress.com/pre-infusion-host-marrow-vulnerability-in-cd19--and-bcma-directed-car--peer-reviewed-fulltext-article-CMAR